Brenda Cooperstone

Insider Reports History

Entity
Individual
Location
C/O Senti Biosciences, Inc., 2 Corporate Drive First Floor, South San Francisco, CA
Signature
/s/ Mike Rhee, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brenda Cooperstone:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Senti Biosciences, Inc. Director Stock Option (Right to Buy) 62.5K Jul 10, 2024 Direct
Lexeo Therapeutics, Inc. Director Stock Option (right to buy) 18K Jun 25, 2024 Direct

Insider Reports Filed by Brenda Cooperstone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNTI Senti Biosciences, Inc. Jul 10, 2024 1 $0 4 Jul 12, 2024 Director
LXEO Lexeo Therapeutics, Inc. Jun 25, 2024 1 $0 4 Jun 27, 2024 Director
LXEO Lexeo Therapeutics, Inc. Nov 2, 2023 0 $0 3 Nov 2, 2023 Director
SNTI Senti Biosciences, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
SNTI Senti Biosciences, Inc. Jul 13, 2022 1 $0 4 Jul 15, 2022 Director
SNTI Senti Biosciences, Inc.\ Jun 8, 2022 0 $0 3 Jun 15, 2022 Director